Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

An immunologist shares tips from a team-based environment

Scientists are using the imaging technique to see complex molecular structures in stunning detail.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.